Literature DB >> 7253936

Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height.

J Poortman, J H Thijssen, F de Waard.   

Abstract

To study the relation between body weight and height and the plasma sex-hormone levels wer measured the plasma levels of oestrone (E1), oestradiol (E2) and androstenedione (A) in a group of healthy post-menopausal women with a wide range of body weight. The sex hormones were measured by radioimmunoassay with highly specific antisera after purification of the plasma extract by column chromatography. Our findings show that there is significant positive correlation between the E1 level and body weight as well as A level and, to a lesser extent, between the E1 level and Quetelet index. For E2 there is no correlation with these parameters. There is also a very slight correlation between A level, body weight and Quetelet index. Calculation of the partial correlation coefficient shows that E1 correlates to the same degree with body weight and A level, whereas the A level does not correlate with body weight at a fixed value for the E1 level. We conclude that variation in the E1 level depends to the same degree on the variation in body weight as well as the variation in A level.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7253936     DOI: 10.1016/0378-5122(81)90021-9

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  6 in total

1.  Endocrine profile in breast cancer patients receiving chemotherapy.

Authors:  R R Mehta; C W Beattie; T K Das Gupta
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

2.  Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer.

Authors:  Erin D Giles; Elizabeth A Wellberg; David P Astling; Steven M Anderson; Ann D Thor; Sonali Jindal; Aik-Choon Tan; Pepper S Schedin; Paul S Maclean
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

Review 3.  Expected and paradoxical effects of obesity on cancer treatment response.

Authors:  Marco Gallo; Valerio Adinolfi; Viola Barucca; Natalie Prinzi; Valerio Renzelli; Luigi Barrea; Paola Di Giacinto; Rosaria Maddalena Ruggeri; Franz Sesti; Emanuela Arvat; Roberto Baldelli; Emanuela Arvat; Annamaria Colao; Andrea Isidori; Andrea Lenzi; Roberto Baldell; M Albertelli; D Attala; A Bianchi; A Di Sarno; T Feola; G Mazziotti; A Nervo; C Pozza; G Puliani; P Razzore; S Ramponi; S Ricciardi; L Rizza; F Rota; E Sbardella; M C Zatelli
Journal:  Rev Endocr Metab Disord       Date:  2020-10-06       Impact factor: 6.514

4.  Hereditary Angioedema with and Without C1-Inhibitor Deficiency in Postmenopausal Women.

Authors:  Aurore Billebeau; Olivier Fain; David Launay; Isabelle Boccon-Gibod; Laurence Bouillet; Delphine Gobert; Geneviève Plu-Bureau; Anne Gompel
Journal:  J Clin Immunol       Date:  2020-10-31       Impact factor: 8.317

Review 5.  Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.

Authors:  Per Eystein Lønning; Hans Petter Eikesdal
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

6.  Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study.

Authors:  A Zeleniuch-Jacquotte; R E Shore; K L Koenig; A Akhmedkhanov; Y Afanasyeva; I Kato; M Y Kim; S Rinaldi; R Kaaks; P Toniolo
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.